Ideally we would like to succeed in the development of a new form of blood type testing kit.
This would, if it works, significantly reduce the costs of production and hence retail of the kits.
This would help the NHS and other healthcare providers around the world which are in need of finding efficiency savings, so they can focus more on implementing improvements to patient care.